SmartStream Launch the Latest Version of TLM Reconciliations Premium to Enable User Independence and Operational Flexibility
SmartStream Technologies, the financial Transaction Lifecycle Management (TLM®) solutions provider, today announced the launch of its latest reconciliations solution. The third major release of its TLM Reconciliations Premium solution comes with a range of services to meet customer requirements for a flexible self-service user experience, comprehensive trend analysis for match rate optimisation and exception reduction, and model choices for each reconciliation – allowing customers to easily shape and form the solution in an innovative way, whilst optimising costs and operational overhead.
The latest release continues SmartStream’s investment in providing a wide-ranging reconciliation solution, delivering additional business benefits at every stage of the lifecycle. A new feature, TLM View, provides a flexible, user driven approach to analytics, with no reliance on IT support, allowing access to the full range of real-time and historic data in the reconciliation repository – this will help identify trends and exception patterns to further reduce manual intervention. TLM View also delivers full operational functionality in one single interface, driven by flexible dashboards and fully customisable by business users.
Another key element of the latest release is TLM SmartRecs, SmartStream’s rapid onboarding and automated match rule creation solution – which now has further features, including data transformation functions and enhanced analysis of incoming data. TLM SmartRecs allows business users to independently model new reconciliations or fine-tune existing reconciliations to improve outcomes.
Rocky Martinez, CTO, SmartStream, states: “With the latest release of TLM Reconciliations Premium we have the infrastructure to allow for robotic process automation (RPA) and have the ability to view distributed ledger information. This is what we view as the future as it becomes industry standard for our customers.”
TLM Reconciliations Premium now provides a choice in how each reconciliation is persisted, TLM Persist offers alternatives that range from a supported relational database management system (RDBMS) to lighter storage options. Regardless of persistence choice, all reconciliations can be accessed through the same user interface, which allows the management of costs and operational overheads, without the need to compromise on user experience.
It has already been in testing with customers and feedback has been positive for the solution which has high operational excellence, scalability and ease of deployment - customers find the solution easy to use and can expect to realise the benefits within the calendar year.
Haytham Kaddoura, CEO, SmartStream, commented; “This major release positions SmartStream with a unique offering, rather than relying on multiple vendors to provide a range of services, we provide a complete and comprehensive package with enhanced features and functionality already built-in. As the first software/service provider to offer an industry-led, purpose-built utility, this new version of our award winning TLM Reconciliations Premium solution is the result of what we have learned over the years combined with what our customers have asked for, creating something unmatched in the marketplace.”
Ends
About SmartStream Technologies
SmartStream Technologies is
a recognised leader in financial transaction management software that
enables firms to overcome critical transaction processing issues through
increased automation.
SmartStream’s industry-leading automated match rates create more proactive, exceptions-based processes that lower the cost per transaction while enabling firms to reduce operational risk, strengthen compliance and controls, and improve customer service.
As a result, more than 1,500 clients, including 75 of the world’s top 100 banks, 8 of the top 10 asset managers, and 8 of the top 10 custodians rely on SmartStream Transaction Lifecycle Management (TLM®) solutions to deliver greater efficiency to their trading operations.
For more information about SmartStream visit: www.smartstream-stp.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171016005170/en/
Contact information
Dina Communications
Shamira Alidina
Media Relations
Director
Tel +44 (0) 7801 590718
Email: shamira@dinacomms.com
or
SmartStream
Technologies
Nathan Gee
Senior Marketing Manager
Tel:
+44 (0) 20 7898 0630
Email: nathan.gee@smartstream-stp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 23:30:00 EEST | Press release
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to existing therapies. Gilteritinib (Xospata®; Astellas Pharma, peak annual sales projection: $1.5 billion) and Quizartinib (Vanflyta®; Daiichi Sankyo) are two FDA-approved FLT3 inhibitors, with the former approved only for relapsed/refractory AML and the latter approved o
IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 23:05:00 EEST | Press release
IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global freight industry. “Einride shares our belief that quantum computing will fundamentally reshape and improve how large industries such as transportation and logistics operate,” said Niccolo de Masi, CEO of IonQ. “This partnership is aimed at creating a powerful platform with u
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 22:26:00 EEST | Press release
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current standard of care for EGFR-positive NSCLC is comprised of 3rd-generation inhibitors, most notably Osimertinib (Tagrisso®), whose annual sales exceed $6 billion. Most patients treated by tyrosine kinase inhibitors (TKIs) will eventually develop
NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 22:24:00 EEST | Press release
NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates
Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 22:08:00 EEST | Press release
As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom